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Abstract: Slow lorises are enigmatic animal that represent the only venomous primate lineage. Their
defensive secretions have received little attention. In this study we determined the full length sequence
of the protein secreted by their unique brachial glands. The full length sequences displayed homology
to the main allergenic protein present in cat dander. We thus compared the molecular features of the
slow loris brachial gland protein and the cat dander allergen protein, showing remarkable similarities
between them. Thus we postulate that allergenic proteins play a role in the slow loris defensive arsenal.
These results shed light on these neglected, novel animals.
Keywords: allergen; dander; evolution; primate; venom
Key Contribution: We show the remarkable similarities between the proteins of cat dander allergen
and slow loris brachial gland secretions. These proteins play a role in the defensive arsenal of
both mammals.
1. Introduction
The origin and evolution of animal defensive and predatory toxins has been the subject of intense
research [1], but that of mammals, possibly because of its infrequent occurrence, has been somewhat
neglected. Employing venoms has evolved several times independently in mammals, including in
solenodons, platypus, vampire bats, water shrews, and a group of primates, the slow lorises [1–7].
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A slow loris when threatened, raises its arms over the head, bringing sebaceous glands located in the
brachial region of the upper arm close to its mouth, the fluid from these brachial glands is mixed with
saliva. The fluid is delivered in a bite with procumbent anterior incisors known as the toothcomb,
which is believed to act as an effective venom delivery system [8]. Although ecological functions may
vary, the toxin is certainly used for intraspecific competition [9]; use in defence against predators is
possible but this requires future to determine. Bitten animals suffer from chronically non-healing
wounds, leading to necrosis, septicaemia, lung oedema, and cellulitis [10,11]. Envenomation in humans
may be followed by paraesthesia, haematuria, dyspnoea, extreme pain, and infection, and in the worst
cases can lead to severe or even near-fatal anaphylactic shock [12–14]. Healing time may reach several
months [13].
Despite this interest in the field, the nature of the secretions produced by the brachial glands of
slow lorises has been studied only to a limited detail from captive animals. The secretions produce a
characteristic odour that has been shown to be due to a complex array of over two hundred aromatic
molecules [15]. While the aromatic compounds have been well-characterised, the protein secretions are
known from only small N-terminal fragments details [15]. BLAST searches [16] revealed both chains
to belong to the same allergenic protein family as does the Felis catus dander allergen Fel d1. Fel d1
is a 35 kDa secretoglobin protein produced by sebaceous, salivary, perianal, and lachrymal glands
as well as squamous epithelial cells, and is distributed by F. catus over its fur during grooming and
licking [17–20]. Structurally F. catus dander allergen Fel d1 is a heterodimer formed by three inter-chain
disulphide bonds. Chain One is 70 residues while chain two is 90 or 92 residues long [21,22]. It has
been shown that the two Chains One and Two are encoded for by different genes [23]. Two copies of
this heterodimer non-covalently associate to form a larger homodimer consisting of Chains A and B.
Several attempts have been made to determine the 3D-structure of F. catus dander allergen Fel d1 [24,25].
In principle, two ways exist to form a heterodimer from Chain One and Two: Chain One followed
by Chain Two or vice versa. When recombinant proteins were investigated both chain arrangements
yielded very similar biochemical, immunological, and structural results, even when compared to their
natural counterpart [26]. Only Chain 1 + 2 arrangement resulted in forming homodimers [24,25]. Thus,
Chain A and B each consists of a Chain 1 + 2 heterodimers.
The limited sequence information is insufficient to reconstruct the molecular evolutionary history
of the slow loris brachial gland secreted proteins and therefore their relationship to F. catus dander
allergen Fel d1 and other proteins within the broader allergen family. In this study, we therefore
elucidate the full-length sequence of both chains of the Javan slow lorises’ (Nycticebus javanicus) brachial
gland secreted proteins, with samples from wild animals. We discuss our findings in the light of
available information from the cat F. catus dander allergens possibly leading to insights not only on the
molecular evolution of mammalian allergens but also gaining a greater understanding how to treat
humans when envenomated by slow lorises.
2. Results and Discussion
Through a combination of MS/MS sequencing and DNA sequencing, we obtained the first full-
length sequences of brachial gland protein of N. javanicus, with the full nucleotide sequence of Chain-
One determined as (tgtcccgccgtagaaaaacacgctaacctcttcctgaagggaaccactgatgaatttctcaattatgcgaaaaatttcgta
aaatcctctgcagtattggaaaatgctaagcaactgaagatgtgttccgacaataaactgacagaagaggataaggataatgtccagtctgggc
tggacaaaatatactcaagcaatttttgt) while Chain Two was sequenced using protein sequencing (Table 1).
We then compared them structurally to the homologous F. catus dander Fel d1 protein. To date,
eight cat dander allergens have been found. They were named Fel d1 to Fel d8 [27,28]. Fel d1 belongs
to the secretoglobulin family, Fel d2 is a serumalbumin, Fel d3 a cystatin, Fel d4 and 7 are lipocalins,
Fel d5 and 6 are Ig antibodies of type A and M, respectively. Further, Fel d8 is a latherin. Despite Fel
d1 Fel d4 is the second most prominent cat dander allergen with 63% of people allergic to cats have
formed antibodies against [29]. Fel d1 was discovered in 1973 and is the most prominent of these
allergens [30]. It accounts for 96% of cat allergies [31]. It is found in every house and public place,
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regardless of the presence of cats. Fel d1 has spread globally and was detected even in regions where
cats most likely have never lived, i.e., the Greenland inland ice shelf. This has been associated with
particle sizes of Fel d1 that can reach less than 4 cm in diameter and thus are susceptible to eolian
distribution [32]. Fel d1 is produced by every cat but the amount produced varies greatly with race,
age, and sex. Adult cats produce more Fel d1 than kittens and male cats more than females. Neutered
cats probably produce similar amounts of Fel d1 than females [33]. It has been postulated that Siberian
and Balinesian cats produced less Fel d1 than most other races. However, the body of data is still
sparse and the topic remains unclear [27]. Any similarity of brachial gland protein of N. javanicus and
cat allergen Fel d1 hints towards a better understanding of the mechanism of action of brachial gland
protein of N. javanicus as well as possible treatments to slow loris bites in humans.
Table 1. Protein sequencing results for Chain 2.
Enzyme
Digest
Initial de novo Sequence
Returned by Peaks Studio ALC (%) m/z z Final Correct Sequence
Trypsin N(+42.01)TLFYGVFGALVTGDK 96 872.4631 2 CPIFYGVFGAIVTGDK
Trypsin NLLDSFLDKVSGTEPEK 96 631.3182 2 NIIDSFIDKVSGTEPEK
Trypsin T(+42.01)TC(+71.06)KLQM(+15.99)AAFNEEGLTGK 92 762.8611 2 IQECFNEEGITGK
Trypsin LTEEDQDNVQSGLDK 97 564.2603 3 LTEEDKDNVQSGLDK
Trypsin Edman degradation VKSSAVLENAK
Trypsin Edman degradation IYSSNFCPIFYGVFGAIVTGDK
AspN DNKLTEEDKN(+.98)NVQSGL 94 902.9345 2 DNKLTEEDKDNVQSGL
LysC LTEEDKDNVQSGLDK 98 845.91 2 LTEEDKDNVQSGLDK
LysC AAFENLKEC (+57.02)FNEEGLTGK 96 1028.9913 2 AAFENIQECFNEEGITGK
Sequence alignment of target to templates revealed that the cysteine residues are conserved
indicating that disulfide bridges are conserved as well (Figure 1). The N. javanicus brachial gland
protein chains are shorter than the F. catus allergen structures as Chain One is missing the first three
N-terminal residues M0, E1, and I2 as well as the C-terminally located V71 to T76. Chain One of the
N. javanicus brachial secretion protein contains 36 out of 68 identical residues corresponding to 52.9%
sequence similarity. In Chain Two, 25 out of 70 residues (35.7%) are identical.
Toxins 2020, 12, x FOR PEER REVIEW 3   
Toxins 2020, 12, x; doi: FOR PEER REVIEW www.mdpi.com/journal/toxins 








m/z z Final Correct Sequence 
Trypsin  N(+42.01) TLFYGVFGALVTGDK 96 872.4631 2 CPIFYGVFGAIVTGDK 




92 762.8611 2 IQECFNEEGITGK 
Trypsin LTEEDQDNVQSGLDK 97 564.2603 3 LTEEDKDNVQSGLDK 
Trypsin Edman degradation VKSSAVLENAK 
Trypsin Edman degradation  
IYSSNFCPIFYGVFGAIVTGD
K 
AspN DNKLTEEDKN(+.98)NVQSGL   94 902.9345 2 DNKLTEEDKDNVQSGL 
LysC LTEEDKDN QSGLDK 98 845.91 2 LTEEDKDNVQSGLDK 
LysC AAFENLKEC (+57.02) FNEEGLTGK 96 1028.9913 2 AAFENIQECFNEEGITGK 
We then compared them structurally to the homologous F. catus dander Fel d1 protein. To date, 
eight cat dander allergens have been found. They were named Fel d1 to Fel d8 [27,28]. Fel d1 belongs 
to the secretoglobulin family, Fel d2 is a serumalbumin, Fel d3 a cystatin, Fel d4 and 7 are lipocalins, 
Fel d5 and 6 are Ig antibodies of type A and M, respectively. Further, Fel d8 is a latherin. Despite Fel 
d1 Fel d4 is the second most prominent cat dander allergen with 63% of people allergic to cats have 
formed antibodies against [29]. Fel d1 was discovered in 1973 and is the most prominent of these 
allergens [30]. It accounts for 96% of cat allergies [31]. It is found in every house and public place, 
regardless of the presence of cats. Fel d1 has spread globally and was detected even in regions where 
cats most likely have never lived, i.e., the Greenland inland ice shelf. This has been associated with 
particle sizes of Fel d1 that can reach less than 4 cm in diameter and thus are susceptible to eolian 
distribution [32]. Fel d1 is produced by every cat but the amount produced varies greatly with race, 
age, and sex. Adult cats produce more Fel d1 than kittens and male cats more than females. Neutered 
cats probably produce similar amounts of Fel d1 than females [33]. It has been postulated that 
Siberian and Balinesian cats produced less Fel d1 than most other races. However, the body of data 
is still sparse and the topic remains unclear [27]. Any similarity of brachial gland protein of N. 
javanicus and cat allergen Fel d1 hints towards a better understanding of the mechanism of action of 
brachial gland protein of N. javanicus as well as possible treatments to slow loris bites in humans. 
 
Figure 1. Sequence alignment of Felis catus (Fc) dander allergen Fel d1 and Nycticebus javanicus (Nj) 
brachial gland secretion protein. Identical residues are shaded in grey. 
Sequence alignment of target to templates revealed that the cysteine residues are conserved 
indicating that disulfide bridges are conserved as well (Figure 1). The N. javanicus brachial gland 
protein chains are shorter than the F. catus allergen structures as Chain One is missing the first three 
N-terminal residues M0, E1, and I2 as well as the C-terminally located V71 to T76. Chain One of the 
N. javanicus brachial secretion protein contains 36 out of 68 identical residues corresponding to 52.9% 
sequence similarity. In Chain Two, 25 out of 70 residues (35.7%) are identical. 
Figure 1. Sequence alignment of Felis catus (Fc) dander allergen Fel d1 and Nycticebus javanicus (Nj)
brachial gland secretion protein. Identic l residues are shaded i grey.
In order to examine the structural evolution of the N. javanicus brachial secretion protein, the
F. catus dander al ergen Fel d1 st uc ure t late 2EJN was first download d from the protein databank
(https://www.rcsb.org) [34] consisting f a h terodimeric homodimer (two no -covalently linke
copi s of a covalently linked heterodimer) (Figure 2). The F. catu dander allergen Fel d1 te odim r
consists of two chains (A and B) linked to each other by three disulfid bonds within each heterodimer.
All three disulfide bonds link together in the format of Cha n A cysteine1 – Chain B cysteine3; Chain
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A cysteine2 – Chain B cysteine3; and Chain A cystine3 – Chain B cysteine1. Each domain consists
of eight α-helices, for each to Chain One and Two, respectively. A Ca2+-binding site at the domain
interface consists of I125 of Domain A and D130 of Domain B as well as N89 from both Domain A
and B and three water molecules [25]. The same structure contains a hydrophobic core consisting of
six residues: F85 (Domain A and B), G131 (Domain A and B), and L132 (Domain A and B) that are
surrounded by hydrogen bond forming amino acids. This core forms the central structural element of
the dimerization site [25]. More remote Ca2+-binding Sites Two and Three involved D46 and M49 in
each of the domains [25]. In addition, there is a glycosylation site at position N103, at a surface loop
connecting helices H6 and H7 [21,35]. Of particular importance for interpreting the diversification of
the N. javanicus brachial gland protein, cavities were identified at the same region in each domain of
F. catus dander allergen Fel d1 2EJN [25]. The volume of these cavities differed significantly in size
(350 Å3 in Domain A versus 730 Å3 in Domain B) due to the differing conformations of the eleven
residue long stretch from E121 to G131 in both domains. Kaiser et al. hypothesised that these cavities
may host progesterone [24,25]. This result would be in accordance to findings of uteroglobin and other
orthologues such as CC16 (Clara cell secretory protein) and ABP (androgen-binding protein) that bind
progesterone, PCB-derivatives (PCB: polychlorinated biphenyl) and androgen [36–40].
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When modelled, as the N. javanicus brachial gland protein chains are shorter than the F. catus
allergen chains, the structures shown for both proteins appear slightly different in shape, despite being
superimposed and rotated the same way, but overall the structures are highly similar (Figure 2), which
is reflective not only of shared molecular evolutionary history but suggestive of similar functionality.
In the N. javanicus brachial secretion protein the critical residue for PLA2 inhibition D44 (homologous
residue D46 in Fel d1) is held in position by two salt bridges from K40 and K52. In F. catus dander
allergen Fel d1 the homologous stabilizing residues are K42 and K54.
Comparative examination of the Ca2+-binding site revealed that in the F. catus dander allergen Fel
d1, the Ca2+-binding site 1 is located in a prominent position at the contact area between Domains A
and B. Four residues form Ca2+-binding site 1: the side chain carbonyl atom of N89 and backbone
carbonyl atom of I125 of Domain A as well as the side chain carbonyl atoms of N89 and D130 of
Domain B. Since the N. javanicus brachial secretion protein was modelled without Ca2+-ions present,
the attractive force of Ca2+ is missing, affecting the side-chain placement of T81(A), T81(B), and D123(B).
Like I125 in F. catus dander allergen Fel d1, the respective T117 (A) orients its backbone carbonyl
toward Ca2+-binding Site One. Despite these differences in side chain orientation, we postulate
that Ca2+-binding Site One is also present in the dimerization area of the N. javanicus brachial
secretion protein.
Comparative examination of the hydrophobic core revealed that the F. catus dander allergen Fel
d1 a hydrophobic core made of six residues, namely F85, G131, and L132 of both Domains A and
B [25]. In the N. javanicus brachial secretion protein this interdomain region is not all hydrophobic: G77
(A and B), D123 (A and B), I124 (A and B). Moreover, it is differently shaped. Where in F. catus dander
allergen Fel d1 the large phenylalanine side chain reaches deep into the cavity, in the N. javanicus
brachial secretion protein there is a glycine. By contrast, the position homologous to G131 of F. catus
dander allergen Fel d1 is in the N. javanicus brachial secretion protein occupied by D123. We postulate
that for the N. javanicus brachial secretion protein the hydrophobic core, therefore, differs from that of
the allergen of F. catus.
Comparative examination of the dimerization site revealed that the two heterodimeric Domains
A and B of F. catus dander allergen Fel d1 and that of the N. javanicus brachial secretion protein form a
homodimer. The interface between the two domains consists of 21 amino acids of Domain A (S29, A31,
Y73, G74, G77, T81, D83, I86, F90, T117, G118, K119, T120, D123, I124, I126, G127, A130, I131, I136, I137)
and 20 residues of Domain B (same residues, except I137). Accessible surface area was calculated for
both domains separately and the homodimer (Table 2). As expected, the number of solvent exposed
surface atoms decreases upon dimerization. This is reflected in a 14% decrease of total accessible area
as compared to the two separate heterodimeric Domains A and B.
Table 2. Accessible surface area of isolated heterodimer Domains A and B and the homodimer. Surface





Area/Energy Surface Atoms Buried Atoms
Domain A 2602.53 4497.99 7100.53 609 439
Domain B 2602.62 4497.99 7100.61 609 439
Homodimer 4730.58 7466.48 12197.06 1170 926
Comparative examination of the glycosylation site revealed that in F. catus dander allergen Fel d1
the glycosylation site N103 lies in the surface loop between helices H6 and H7. The corresponding
residue in the N. javanicus brachial secretion protein is S95. Serine can be O-glycosylated and
therefore glycosylation may occur at the same structural position as in F. catus dander allergen Fel d1
structure 2EJN.
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Kaiser et al. postulated immunoglobulin E (IgE)-binding to solvent exposed residues [24]. IgE is
an antibody that is known to play a crucial role in type I hypersensitivity. Type I hypersensitivity has
been linked to allergic asthma, sinusitis, allergic rhinitis, food allergies, chronic urticaria, and atopic
dermatitis. It is involved in allergen response, e.g. bee stings or anaphylactic drugs [42]. The apparent
similarity of residues in F. catus dander allergen Fel d1, and the N. javanicus brachial secretion protein
hints toward a similar function. F. catus dander allergen Fel d1 was identified several decades ago
and is responsible for the immunoglobulin IgE-response in 90–95% of patients who are allergic to
F. catus [31,43]. The body of work carried out in this study revealed that not only F. catus dander
allergen Fel d1 may be able to trigger an immune response. A number of proteins exist in evolutionary
distant animals that potentially can act similar to the major F. catus allergen. Of particular note is the
molecular similarity between the N. javanicus brachial secretion protein and F. catus dander allergen Fel
d1 which suggests a functional similarity that is consistent with known reactions to Nycticebus bites.
We postulate that approaches to treat cat allergy, such as desensitization, may work for researchers and
caretakers of slow lorises as well [44–46]. Furthermore, understanding the causes of allergic reactions
up to anaphylactic shock greatly enhances chances for successful treatment of slow loris’ bites.
Future work should investigate the potential role of immunological feedback loops that are
overstimulated and may explain the festering, non-healing wounds characteristic of slow loris bites.
Treatment with cat antiallergens may be a starting point.
3. Materials and Methods
3.1. Brachial Gland Secretion
We obtained brachial gland secretions of Nycticebus javanicus from wild slow lorises studied
at the ecological research station in Cipaganti, Garut Regency, West Java, Indonesia (S7◦6’6–7◦7’0&
E 107◦46’0–107◦46’5). We collected samples used here from April 2012 to June 2014, during which
time we captured the animals for health checks associated with a radio-tracking project [47]. After
capture, we manually held the non-anaesthetized animals and gently used a sterile swab to collect
the brachial secretion (supplementary video 1). Each swab was then contained, sealed with parafilm,
and frozen at −80 ◦C. Samples were exported from Indonesia to Australia in August 2016 with
approval from the Indonesian Ministry of Forestry, Indonesia’s CITES Management Authority, and
Australia’s Department of Environment. The work was conducted under the RISTEK research permits
039/SIP/FRP/SM/11/2012, 11/TKPIPA/FRP/SM/11/2013, and 163/SPP/RPB/WU/5/2014. The Animal
Ethics Subcommittee of Oxford Brookes University’s University Research Ethics Committee approved
this research.
3.2. MS/MS
Protein was first desalted on C8 column, and resuspended in 100 mM ammonium bicarbonate.
Protein was reduced with 10 mM DTT, 95 ◦C, 15 min, cooled to room temperature, and alkylated with
iodoacetamide (25 mM final concentration) for 30 min, RT in the dark. Additional DTT (1ul, 100 uM)
was added to quench excess iodoacetamide. The sample was split into aliquots, and digestion was
performed overnight at 37 ◦C with either trypsin, chymotrypsin, AspN, GluC or LysC. Samples were
ziptipped (C18, 0.6 ul resin, MerckMillipore) before analysis by mass spectrometry.
3.3. LC-MS/MS Analysis
Peptides were separated using reversed-phase chromatography on a Shimadzu Prominence
nanoLC system. Using a flow rate of 30 µL/min, samples were desalted on an Agilent C18 trap
(0.3 × 5 mm, 5 µm) for 3 min, followed by separation on a Vydac Everest C18 (300 A, 5 µm,
150 mm × 150 µm) column at a flow rate of 1 µL/min. A gradient of 10–60% buffer B over 30 min
where buffer A = 1 % ACN / 0.1% FA and buffer B = 80% ACN / 0.1% FA was used to separate peptides.
Eluted peptides were directly analyzed on a TripleTof 5600 instrument (ABSciex) using a Nanospray
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III interface. Gas and voltage settings were adjusted as required. MS TOF scan across m/z 350–1800
was performed for 0.5 sec followed by information dependent acquisition of up to 20 peptides across
m/z 40–1800 (0.05 sec per spectra).
LC-MS/MS data was de novo sequenced using PeaksStudio software, with enzyme specified based
on sample, mass tolerance of 20 ppm, fragment mass tolerance of 0.1 Da, and variable modifications
including oxidation of methionine, and carbamidomethylation set as fixed modification. Resulting de
novo sequences were manually curated and validated, with sequences BLAST searched to determine
other proteins with similarity.
3.4. mRNA
The 3’ rapid amplification of cDNA ends (RACE) first strand cDNA was synthesized from
34 ng total RNA using the FirstChoice RLM-RACE kit (Ambion), following the manufacturer’s
instructions. The resulting cDNA was used as template in a polymerase chain reaction (PCR)
using a forward primer (F) designed from the partial α-chain venom peptide sequence and
a reverse 3’RACE outer primer supplied in the FirstChoice RLM-RACE kit (Ambion). The
known peptide sequence was reverse-translated into a nucleotide sequence for primer design.
Primer sequences were F=5’-GGTGGAAAAACATGCGAAC-3’ and 3’RACE outer primer =
5’-GCGAGCACAGAATTAATACGACT-3’. The PCR reaction was performed using FastStart Taq DNA
polymerase (Roche) with 3’RACE-cDNA as template under the following cycling conditions: 95 ◦C
for 4 min, followed by 40 cycles of 95 ◦C for 30 s, 58 ◦C for 30 s, and 72 ◦C for 1 min and a final
elongation step at 72 ◦C for 7 min. PCR products were analyzed and purified after separation on a 1%
agarose gel using a QIAquick Gel Extraction kit (Qiagen) and cloned into vector pCR2.1 (Invitrogen)
for sequencing by the Australian Genome Research Facility using an M13 forward primer.
3.5. Modeling
In order to structurally modelling of Chain 1 + 2 heterodimers and homodimers of Chain A and B,
the target sequence was aligned to the template sequence of the major F. catus allergen Fel d1 in Swiss
PDB Viewer [48]. The major F. catus allergen Fel d1 template structures 1ZKR and 2EJN [24,25] were
downloaded from the PDB (www.rcsb.org) [34]. It was used as the template for all molecules in this
study. The target sequences A and B were aligned to the template and target to template sequence
alignments were exported in gapped FASTA-format from SPDBV [48]. The alignment was read in
Chimera (University of San Francisco), version 1.8 [49]. Models were created using MODELLER [50]
through UCSF Chimera as a Graphical User Interface. Due to the overall high sequence identity
between target and template the series of models obtained from MODELLER were very similar.
Therefore, the first model with the lowest overall energy was chosen. The model structures were
generated in SPDBV [48] and side chains were cleaned up by following energy minimization of 20 and
two times 100 steps of steepest descent minimization as implemented in SPDBV. Interface residues
were identified by calculating contact surfaces of neighbouring domains in the homodimer using
InterProSurf [51]. Hydrophobic patches were identified by calculating the respective surfaces in
SPDBV. Surface charges were calculated using the APBS-algorithm [52] as implemented in VMD [53].
The calculated potential-maps were loaded to the protein under inspection. Surfaces were visualized
applying the “surf” option and colouring method “volume” in VMD. The range for positive (blue) to
negative charges (red) was set to −20.00 and 20.00, respectively.
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